MYC and diffuse large B-cell lymphoma: Moreover, DLBCL with dual expression of the MYC and BCL2 proteins (double expresser DLBCL) had a poor prognosis with increased risk of CNS relapse, predominantly associated with non-germinal center B-cell (non-GCB) subtype, as per Hans algorithm [22].